Evaxion Biotech AS (EVAX)
1.49
+0.12
(+8.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.42
-0.07
(-4.70%)
After-Hours: 20:00
Evaxion Biotech Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -0.028M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -25.95M |
| September 30, 2021 | -0.001M |
| June 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2021 | -27.90M |
| December 31, 2020 | -2.393M |
| September 30, 2020 | -6.626M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-27.90M
Minimum
Mar 2021
--
Maximum
Mar 2020
-6.290M
Average
-0.0145M
Median
Stock Buybacks (Quarterly) Benchmarks
| Ascendis Pharma AS | -- |
| DBV Technologies SA | -0.007M |
| Adaptimmune Therapeutics PLC | 0.00 |
| Akari Therapeutics PLC | 0.133M |
| Biodexa Pharmaceuticals PLC | -- |